Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia

H. J. Kim, Hyung Chul Lee, Y. S. Jung, Ji Hyun Lee, J. J. Min, D. M. Hong, Eue Keun Choi, Seil Oh, Yunseok Jeon

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background. Palonosetron is a recently introduced 5-HT3 receptor antagonist for postoperative nausea and vomiting. Detailed standardized evaluation of corrected QT (QTc) interval change by palonosetron under sevoflurane anaesthesia is lacking. We evaluated QTc intervals in patients who are undergoing surgery with sevoflurane anaesthesia and receive palonosetron. Methods. Our study included 100 patients who were undergoing elective surgery under sevoflurane anaesthesia. The patients were randomly assigned to two groups: those who received an i.v. injection of palonosetron 0.075 mg immediately before induction of anaesthesia (pre-surgery group, n=50) and those who received it after surgery in the recovery room (post-surgery group, n=50). QTc intervals were measured before operation, intraoperatively (baseline, immediately after tracheal intubation, and at 2, 10, 15, 30, 60, and 90 min after administration of palonosetron or placebo), and after operation (before and at 3, and 10 min after administration of palonosetron or placebo). QTc intervals were calculated using Fridericia's, Bazett's, or Hodges formulas. Results. The perioperative QTc intervals were significantly increased from the baseline values, but were not affected by the pre-or post-surgical timing of palonosetron administration. Conclusions. There was no significant difference in the QTc intervals during the perioperative period, whether 0.075 mg of palonosetron is administered before or after sevoflurane anaesthesia. Palonosetron may be safe in terms of QTc intervals during sevoflurane anaesthesia.

Original languageEnglish
Pages (from-to)460-468
Number of pages9
JournalBritish Journal of Anaesthesia
Volume112
Issue number3
DOIs
StatePublished - 1 Mar 2014

Fingerprint

Anesthesia
Placebos
Serotonin 5-HT3 Receptor Antagonists
Recovery Room
palonosetron
sevoflurane
Receptors, Serotonin, 5-HT3
Postoperative Nausea and Vomiting
Perioperative Period
Intubation
Injections

Keywords

  • anti-emetics
  • electrocardiography
  • palonosetron
  • postoperative nausea and vomiting
  • sevoflurane

Cite this

@article{24107958279347c2992243d3f18ca2d7,
title = "Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia",
abstract = "Background. Palonosetron is a recently introduced 5-HT3 receptor antagonist for postoperative nausea and vomiting. Detailed standardized evaluation of corrected QT (QTc) interval change by palonosetron under sevoflurane anaesthesia is lacking. We evaluated QTc intervals in patients who are undergoing surgery with sevoflurane anaesthesia and receive palonosetron. Methods. Our study included 100 patients who were undergoing elective surgery under sevoflurane anaesthesia. The patients were randomly assigned to two groups: those who received an i.v. injection of palonosetron 0.075 mg immediately before induction of anaesthesia (pre-surgery group, n=50) and those who received it after surgery in the recovery room (post-surgery group, n=50). QTc intervals were measured before operation, intraoperatively (baseline, immediately after tracheal intubation, and at 2, 10, 15, 30, 60, and 90 min after administration of palonosetron or placebo), and after operation (before and at 3, and 10 min after administration of palonosetron or placebo). QTc intervals were calculated using Fridericia's, Bazett's, or Hodges formulas. Results. The perioperative QTc intervals were significantly increased from the baseline values, but were not affected by the pre-or post-surgical timing of palonosetron administration. Conclusions. There was no significant difference in the QTc intervals during the perioperative period, whether 0.075 mg of palonosetron is administered before or after sevoflurane anaesthesia. Palonosetron may be safe in terms of QTc intervals during sevoflurane anaesthesia.",
keywords = "anti-emetics, electrocardiography, palonosetron, postoperative nausea and vomiting, sevoflurane",
author = "Kim, {H. J.} and Lee, {Hyung Chul} and Jung, {Y. S.} and Lee, {Ji Hyun} and Min, {J. J.} and Hong, {D. M.} and Choi, {Eue Keun} and Seil Oh and Yunseok Jeon",
year = "2014",
month = "3",
day = "1",
doi = "10.1093/bja/aet335",
language = "English",
volume = "112",
pages = "460--468",
journal = "British journal of anaesthesia",
issn = "0007-0912",
publisher = "Elsevier Ltd",
number = "3",

}

Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia. / Kim, H. J.; Lee, Hyung Chul; Jung, Y. S.; Lee, Ji Hyun; Min, J. J.; Hong, D. M.; Choi, Eue Keun; Oh, Seil; Jeon, Yunseok.

In: British Journal of Anaesthesia, Vol. 112, No. 3, 01.03.2014, p. 460-468.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia

AU - Kim, H. J.

AU - Lee, Hyung Chul

AU - Jung, Y. S.

AU - Lee, Ji Hyun

AU - Min, J. J.

AU - Hong, D. M.

AU - Choi, Eue Keun

AU - Oh, Seil

AU - Jeon, Yunseok

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Background. Palonosetron is a recently introduced 5-HT3 receptor antagonist for postoperative nausea and vomiting. Detailed standardized evaluation of corrected QT (QTc) interval change by palonosetron under sevoflurane anaesthesia is lacking. We evaluated QTc intervals in patients who are undergoing surgery with sevoflurane anaesthesia and receive palonosetron. Methods. Our study included 100 patients who were undergoing elective surgery under sevoflurane anaesthesia. The patients were randomly assigned to two groups: those who received an i.v. injection of palonosetron 0.075 mg immediately before induction of anaesthesia (pre-surgery group, n=50) and those who received it after surgery in the recovery room (post-surgery group, n=50). QTc intervals were measured before operation, intraoperatively (baseline, immediately after tracheal intubation, and at 2, 10, 15, 30, 60, and 90 min after administration of palonosetron or placebo), and after operation (before and at 3, and 10 min after administration of palonosetron or placebo). QTc intervals were calculated using Fridericia's, Bazett's, or Hodges formulas. Results. The perioperative QTc intervals were significantly increased from the baseline values, but were not affected by the pre-or post-surgical timing of palonosetron administration. Conclusions. There was no significant difference in the QTc intervals during the perioperative period, whether 0.075 mg of palonosetron is administered before or after sevoflurane anaesthesia. Palonosetron may be safe in terms of QTc intervals during sevoflurane anaesthesia.

AB - Background. Palonosetron is a recently introduced 5-HT3 receptor antagonist for postoperative nausea and vomiting. Detailed standardized evaluation of corrected QT (QTc) interval change by palonosetron under sevoflurane anaesthesia is lacking. We evaluated QTc intervals in patients who are undergoing surgery with sevoflurane anaesthesia and receive palonosetron. Methods. Our study included 100 patients who were undergoing elective surgery under sevoflurane anaesthesia. The patients were randomly assigned to two groups: those who received an i.v. injection of palonosetron 0.075 mg immediately before induction of anaesthesia (pre-surgery group, n=50) and those who received it after surgery in the recovery room (post-surgery group, n=50). QTc intervals were measured before operation, intraoperatively (baseline, immediately after tracheal intubation, and at 2, 10, 15, 30, 60, and 90 min after administration of palonosetron or placebo), and after operation (before and at 3, and 10 min after administration of palonosetron or placebo). QTc intervals were calculated using Fridericia's, Bazett's, or Hodges formulas. Results. The perioperative QTc intervals were significantly increased from the baseline values, but were not affected by the pre-or post-surgical timing of palonosetron administration. Conclusions. There was no significant difference in the QTc intervals during the perioperative period, whether 0.075 mg of palonosetron is administered before or after sevoflurane anaesthesia. Palonosetron may be safe in terms of QTc intervals during sevoflurane anaesthesia.

KW - anti-emetics

KW - electrocardiography

KW - palonosetron

KW - postoperative nausea and vomiting

KW - sevoflurane

UR - http://www.scopus.com/inward/record.url?scp=84896884176&partnerID=8YFLogxK

U2 - 10.1093/bja/aet335

DO - 10.1093/bja/aet335

M3 - Article

C2 - 24129597

AN - SCOPUS:84896884176

VL - 112

SP - 460

EP - 468

JO - British journal of anaesthesia

JF - British journal of anaesthesia

SN - 0007-0912

IS - 3

ER -